Silenseed Competitors and Similar CompaniesClear all
Silenseed's competitors and similar companies include Nektar Therapeutics, Puma Biotechnology, IDEAYA Biosciences and Heidelberg Pharma.
 Silenseed Silenseed is a biopharmaceutical company developing RNA interference (RNAi)-based cancer drugs. |  Puma Biotechnology Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer. |  Heidelberg Pharma Heidelberg Pharma is a drug development company that provides pre-clinical drug discovery and development services for the development of anti-cancer and anti-inflammatory drugs to pharmaceutical and biotechnology industries. | |||
Founding Date | Founding Date 1999 | Founding Date 1990 | Founding Date 2010 | Founding Date 2015 | Founding Date 1997 |
Type | Type Private | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Modi'in-Maccabim-Re'ut, IL HQ | Locations San Francisco, US HQ Hyderabad, IN Huntsville, US | Locations Los Angeles, US HQ | Locations South San Francisco, US HQ San Diego, US | Locations Ladenburg, DE HQ Ladenburg, DE |
Employees | Employees 4 | Employees 61821% increase | Employees 27214% decrease | Employees 56 | Employees 60 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 233.8 m | Valuation ($) 136.8 m | Valuation ($) 2.5 b | Valuation ($) 158.3 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $55.2m (FY, 2025) | Revenue (est.) $228.4m (FY, 2025) | Revenue (est.) $218.7m (FY, 2025) | Revenue (est.) €1.5m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $58.2m (FY, 2025) | Cost of goods N/A | Cost of goods (€2.5m) (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $170.2m (FY, 2025) | Gross profit N/A | Gross profit €6.3m (FY, 2025) |
Net income | Net income N/A | Net income ($164.1m) (FY, 2025) | Net income N/A | Net income ($113.7m) (FY, 2025) | Net income (€42.3m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 10.5m | Total funding raised $ 45m | Total funding raised $ 172m | Total funding raised $ 140m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Nektar Therapeutics
HQ
San Francisco, US
Employees
618↑ 21% increase
Nektar Therapeutics is a stage-clinical biopharmaceutical company.
View companyPuma Biotechnology
HQ
Los Angeles, US
Employees
272↓ 14% decrease
Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.
View company
IDEAYA Biosciences
HQ
South San Francisco, US
Employees
56
IDEAYA Biosciences (IDEAYA) is a developer of molecular therapies.
View companyHeidelberg Pharma
HQ
Ladenburg, DE
Employees
60
Heidelberg Pharma is a drug development company that provides pre-clinical drug discovery and development services for the development of anti-cancer and anti-inflammatory drugs to pharmaceutical and biotechnology industries.
View company